NCT06567028Completed
OSPM-Enhanced AI Model to Identify Premalignant and Malignant Ocular Surface Tumors
Prospective Evaluation of an OSPM-Enhanced Deep Learning Model for Identifying Premalignant and Malignant Ocular Surface Tumors
Source: ClinicalTrials.gov · Last updated 26 Mar 2025
Brief summary (registry, in English)
An OSPM-enhanced deep learning model has been developed for identifying premalignant and malignant tumors using data retrospectively collected from the Ningbo Eye Hospital, Jiangdong Eye Hospital, and the Eye Hospital of Wenzhou Medical University. To further substantiate the model's effectiveness, we intend to evaluate it prospectively at Ningbo Eye Hospital.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 150 (actual)
- First submitted
- 20 Aug 2024
- Start date
- 1 Jun 2024
- Primary completion date
- 1 Oct 2024
- Lead sponsor
- Ningbo Eye Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT06567028
What you commit to
- Study type: Observational
- Participants enrolled: 150
- From 1 Jun 2024 to the primary completion date, 1 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- ● Low-quality images
Who the study is looking for
- ● Ocular surface tumor images with histopathological findings
Age in the registry: 1 year to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ningbo Eye Hospital Coordinator of this site? Confirm its status | Ningbo | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.